(65) opened discussions on the increasing evidence obtained from individuals who spontaneously control infection without antiretroviral therapy, providing a clear rationale for development of a CD8+ T cell-based HIV vaccine alongside B cell vaccine studies. The gene discussed is CD8A; the disease is infection.